“…Additionally, tyrosine is uncharged at physiological pH, and therefore, tyrosine modifications do not alter the surface charge of proteins in contrast to those that modify charged residues like lysine . As such, several new tyrosine conjugation strategies have been developed in the past decade including 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) and sulfur fluoride exchange (SuFeX) analogues, among others. − Such strategies have shown utility in a range of applications for protein modification and functionalization including manufacturing of antibody drug conjugates (ADCs). , Amidst the advances, the oldest tyrosine bioconjugation strategy, aryl diazonium ions to form azo-bonds, remains one of the most heavily utilized. , Though effective, aryl diazonium ions generally require generation under highly acidic conditions, and the salts are both prone to degradation and exhibit shock sensitivity, making long-term storage a challenge. , Further complicating storage, aryl diazonium ions are susceptible to hydrolysis at biologically relevant pH . Despite the limitations, aryl diazonium ions remain a quintessential tool within the realm of bioconjugate chemistry due to their reactivity and relative selectivity.…”